Table 2.
Comparison of observation results of prognosis and quality of life of different examination methods.
| Grouping | By stages | n | One year survival rate | One year recurrence rate | Lymphatic metastasis rate | Hematogenous metastasis rate |
|---|---|---|---|---|---|---|
| Observation group | I | 52 | 49(94.2) | 5(9.6) | 4(7.7) | 5(9.6) |
| I-II | 44 | 40(90.9) | 6(13.6) | 5(11.4) | 6(13.6) | |
| II | 38 | 23(60.5) | 12(31.6) | 14(36.8) | 13(34.2) | |
| Reference group | I | 53 | 44(83.0) | 12(22.6) | 10(18.9) | 13(29.5) |
| I-II | 43 | 38(88.4) | 8(18.6) | 6(14.0) | 9(20.9) | |
| II | 38 | 19(50.0) | 18(47.4) | 16(42.1) | 15(39.5) | |
| I t value | 9.265 | 2.461 | 2.013 | 2.541 | ||
| I P value | 0.008 | 0.003 | 0.002 | 0.004 | ||
| I-II T value | 8.852 | 7.265 | 6.954 | 7.015 | ||
| I-II p value | 0.008 | 0.004 | 0.003 | 0.005 | ||
| II t value | 8.154 | 7.854 | 3.015 | 4.251 | ||
| II p value | 0.009 | 0.006 | 0.004 | 0.007 | ||